Insider Transactions in Q1 2023 at Kinnate Biopharma Inc. (KNTE)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Neha Krishnamohan CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,721
-2.49%
|
$8,605
$5.21 P/Share
|
|
Mar 01
2023
|
Mark A Meltz COO GENERAL COUNSEL SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
638
-2.28%
|
$3,190
$5.21 P/Share
|
|
Mar 01
2023
|
Richard Thomas Williams CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
638
-0.94%
|
$3,190
$5.21 P/Share
|
|
Feb 17
2023
|
Orbimed Advisors LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,100,000
+50.0%
|
-
|
|
Feb 17
2023
|
Carl L Gordon Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,100,000
+50.0%
|
-
|
|
Feb 17
2023
|
James B. Tananbaum |
BUY
Other acquisition or disposition
|
Indirect |
1,100,000
+35.77%
|
-
|
|
Feb 17
2023
|
Foresite Capital Management Iv, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,100,000
+35.77%
|
-
|